Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Belite Bio's Stargardt disease update at the BofA Healthcare Conference puts the retinal gene therapy niche in focus, with readthrough to funding conditions and M&A appetite.
The dollar strengthened as a Trump-Xi meeting revived trade-war fears and reinforced expectations that the Fed will keep rates elevated. The move pressured Indian ADRs and gold.
Nanosecond pulsed field ablation induces programmed cell death, a mechanism that could leapfrog current PFA systems and disrupt large ablation markets. Clinical data from ongoing trials is the next catalyst.
The Senior Citizens League raised its 2027 COLA estimate to 3.9%. Benefits have lost 13.7% of purchasing power since 2016, requiring a $296 monthly catch-up. Next CPI print in mid-June.
Management described a U.S. business reset as stable, removing a key overhang. The next catalyst is the follow-up on margin guidance and debt reduction.
Kestra Medical Technologies' consistent post-IPO execution, highlighted at BofA's healthcare conference, lowers the perceived risk premium for other newly public device companies. The read-through extends to wearable cardiac peers.
Henry Schein reaffirmed its 2026 outlook and a $125M net run-rate target, backed by Q1 dental and tech growth and mid-single-digit medical ex-flu. Q2 report tests cost-save plan.
The Fed chair's decisions ripple through Treasury yields, the dollar, commodities, and growth stocks. The next FOMC meeting is the immediate catalyst.
The 30-year Treasury yield crossed 5.0%, a level not sustained since August 2007. The repricing in long-end bonds transmits through higher mortgage rates, a firmer dollar, and pressure on growth-equity valuations.
Rothbard ranked war finance from least to most destructive: selling assets, borrowing, taxing consumption, taxing savings, and money printing. The financing mix determines the secondary market impact on gold, yields, and the dollar.
Prediction markets price 86% chance of China Boeing order and 81% odds of tariff truce extension. Barclays sees tariff cut if aircraft, oil, soybeans bought.
James Hall & Co. Ltd’s Spar Forward event highlighted expanded food manufacturing, fresh ranges, and Food To Go, signaling a shift in supply chains that will feed into UK food inflation and freight demand.
United Therapeutics partners with Varda Space Industries to test microgravity manufacturing of drugs for chronic diseases, potentially reshaping biotech pipelines.
Treasury yields jumped and the dollar rallied as traders slashed bets on a June rate cut. The repricing tightens financial conditions globally, raising the stakes for the next inflation data.
CEO Joseph DeVivo says 20% of serious-condition patients are first misdiagnosed, and point-of-care ultrasound can change that. The readthrough for traditional imaging players is direct.
India’s April CPI hit 3.5%, a 13-month high, as food inflation reached 4.2%. Rising costs and a weak rupee put rate hikes on RBI’s table ahead of monsoon risks.
Management cited double-digit Q1 growth across TAVR, surgical, mitral, and tricuspid segments, signaling that the entire structural heart market is expanding. The next test is the Q2 earnings report.
Hotter-than-expected April inflation and renewed Iran strike risk hit Asian equities, with South Korea's Kospi falling 2.15%. Next catalyst: Trump-Xi meeting trade talks.
GRAIL CFO Aaron Freidin says private-pay digital health channels are performing well, reducing dependence on the NHS Galleri trial. Next catalyst: quarterly channel growth data.
CFO Joel Ackerman addressed Q1 treatment volumes at the BofA conference, keeping the focus on the metric that drives dialysis stocks. The next tradeable signal arrives with Q2 earnings and the CMS rate update.
CRISPR Therapeutics expects data from six pipeline programs within 12–18 months, starting with cardiovascular disease. The readouts shift focus from CASGEVY's launch to platform validation.
Nmbr's embedded payroll API has already signed 25 partners, moving Canada toward a 70-firm competitive equilibrium. The next step: international expansion.
Bank of England outreach finds middle-income households scaling back, savings drawn down, and youth unemployment at 14.9%, complicating the MPC's rate path.
The 6-3 vote kept borrowing costs at a 30-year high. The near-doubling of the 2026 inflation forecast resets the rate-hike timeline and yen dynamics.
David Malpass says China's food and fertiliser stockpiling worsens a global supply crisis as Hormuz closure disrupts shipments. He expects US inflation to rise.
SF Fed: Industries with AI pricing saw 0.17% extra price decline after surprise rate hike, signaling a faster transmission channel that could lower output costs of tightening.
University of Michigan consumer sentiment index hit a post-1952 low for the second straight month, undercutting the White House confidence narrative. The collapse forces a repricing of rate-cut expectations and the dollar.
Dallas Fed's Logan, a 2026 voter, says inflation still too high, keeping rate cuts on hold. Higher yields and a strong dollar may pressure equities and gold.
Leggett & Platt signed an acquisition deal offering a 10-15% premium. The spread reflects deal-closing risk in a volatile macro environment. Next catalyst: shareholder vote.
The disbursement brings total IMF support to $4.8B under the $7B programme, but the next review will test Pakistan's fiscal consolidation and energy reforms.